Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease
Open accessThe DOI matches its Crossref record; 156 of the 159 references it cites were found in a registry or an index.
Abstract
The identification of biomarkers for early diagnosis of Parkinson’s disease (PD) is of pivotal importance for improving approaches for clinical intervention. The use of translatable animal models of pre-motor PD therefore offers optimal opportunities for novel biomarker discovery in vivo. Peptidylarginine deiminases (PADs) are a family of calcium-activated enzymes that contribute to protein misfolding through post-translational deimination of arginine to citrulline. Furthermore, PADs are an active regulator of extracellular vesicle (EV) release. Both protein deimination and extracellular vesicles (EVs) are gaining increased attention in relation to neurodegenerative diseases, including in PD, while roles in pre-motor PD have yet to be investigated. The current study aimed at identifying protein candidates of deimination in plasma and plasma-EVs in a rat model of pre-motor PD, to assess putative contributions of such post-translational changes in the early stages of disease. EV-cargo was further assessed for deiminated proteins as well as three key micro-RNAs known to contribute to inflammation and hypoxia (miR21, miR155, and miR210) and also associated with PD. Overall, there was a significant increase in circulating plasma EVs in the PD model compared with sham animals and inflammatory and hypoxia related microRNAs were significantly increased in plasma-EVs of the pre-motor PD model. A significantly higher number of protein candidates were deiminated in the pre-motor PD model plasma and plasma-EVs, compared with those in the sham animals. KEGG (Kyoto encyclopedia of genes and genomes) pathways identified for deiminated proteins in the pre-motor PD model were linked to “Alzheimer’s disease”, “PD”, “Huntington’s disease”, “prion diseases”, as well as for “oxidative phosphorylation”, “thermogenesis”, “metabolic pathways”, “Staphylococcus aureus infection”, gap junction, “platelet activation”, “apelin signalling”, “retrograde endocannabinoid signalling”, “systemic lupus erythematosus”, and “non-alcoholic fatty liver disease”. Furthermore, PD brains showed significantly increased staining for total deiminated proteins in the brain vasculature in cortex and hippocampus, as well as increased immunodetection of deiminated histone H3 in dentate gyrus and cortex. Our findings identify EVs and post-translational protein deimination as novel biomarkers in early pre-motor stages of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In AD, EVs are enriched in APP fragments, tau, and synaptic proteins; in PD, they carry citrullinated protein signatures, α-syn, SNAP23, and calbindin; and in HD, they contain N-terminal fragments of mutant huntingtin protein with expanded polyglutamine repeats [30,31,32].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [31]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“EVs further complement these processes by transporting molecules across the extracellular space, enabling stable intercellular communication and key protein distributions [30,31].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [31]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In AD, EVs are enriched in APP fragments, tau, and synaptic proteins; in PD, they carry citrullinated protein signatures, α-syn, SNAP23, and calbindin; and in HD, they contain N-terminal fragments of mutant huntingtin protein with expanded polyglutamine repeats [30,31,32].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [31]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In AD, EVs are enriched in APP fragments, tau, and synaptic proteins; in PD, they carry citrullinated protein signatures, α-syn, SNAP23, and calbindin; and in HD, they contain N-terminal fragments of mutant huntingtin protein with expanded polyglutamine repeats [30,31,32].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [31]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
Vossenaar, E. R., Zendman, A. J. W., van Venrooij, W. J., & Pruijn, G. J. M. (2003) · BioEssays · doi:10.1002/bies.10357 · Cited by 983 · cited 1×
“Peptidylarginine deiminases (PADs) are a family of calcium-activated enzymes that contribute to protein misfolding, as well as changes in protein function, through post-translational deimination of arginine to citrulline [1,2].”
BackgroundFasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., & Meinl, E. (2009) · Brain · doi:10.1093/brain/awp300 · Cited by 595
Citrullination: A posttranslational modification in health and disease
György, B., Tóth, E., Tarcsa, E., Falus, A., & Buzás, E. I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.03.008 · Cited by 500 · cited 1×
“Peptidylarginine deiminases (PADs) are a family of calcium-activated enzymes that contribute to protein misfolding, as well as changes in protein function, through post-translational deimination of arginine to citrulline [1,2].”
BackgroundTurning 21: Induction of miR-21 as a Key Switch in the Inflammatory Response
Sheedy, F. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00019 · Cited by 496
Parkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486 · cited 2×
“Furthermore, in PD iPSC neuronal models, derived from fibroblasts of patients carrying α-synuclein triplication [15], an increase and change in deiminated protein patterns has also been reported [9].”
BackgroundResultGap Junctions: Basic Structure and Function
Meşe, G., Richard, G., & White, T. W. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700770 · Cited by 470 · cited 1×
“Gap junctions are formed by pannexins and connexins and allow for exchange of ions, second messengers, and small metabolites between adjacent cells [75].”
BackgroundExtracellular Vesicles and Neurodegenerative Diseases
Hill, A. F. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0147-18.2019 · Cited by 437 · cited 1×
“EVs are a recognized contributor to neurodegenerative diseases, and both neurotoxic and neuroprotective roles via distribution of EV-mediated cargo, including microRNAs and misfolded proteins, have been implicated [16,17].”
BackgroundChen, Z., Li, Y., Zhang, H., Huang, P., & Luthra, R. (2010) · Oncogene · doi:10.1038/onc.2010.193 · Cited by 426
Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094839 · Cited by 385
MiR-210 – micromanager of the hypoxia pathway
Huang, X., Le, Q.-T., & Giaccia, A. J. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.03.004 · Cited by 376
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain
Reaux, A., De Mota, N., Skultetyova, I., Lenkei, Z., El Messari, S., Gallatz, K., Corvol, P., Palkovits, M., & Llorens‐Cortès, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00320.x · Cited by 374
Mitochondrial uncoupling proteins in the cns: in support of function and survival
Andrews, Z. B., Diano, S., & Horvath, T. L. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1767 · Cited by 364 · cited 1×
“Thermogenesis is related to mitochondrial function [57,58] and also linked to synaptic transmission and neurodegeneration [59].”
BackgroundTriggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis
Johnson, M. E., Stecher, B., Labrie, V., Brundin, L., & Brundin, P. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.09.007 · Cited by 310
Ishigami, A., Ohsawa, T., Hiratsuka, M., Taguchi, H., Kobayashi, S., Saito, Y., Murayama, S., Asaga, H., Toda, T., Kimura, N., et al. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20431 · Cited by 297
Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis
Wang, S., & Wang, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.07.003 · Cited by 285
Oxidative Stress in Parkinson's Disease: A Systematic Review and Meta-Analysis
Wei, Z., Li, X., Li, X., Liu, Q., & Cheng, Y. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00236 · Cited by 281
microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease
Thome, A. D., Harms, A. S., Volpicelli-Daley, L. A., & Standaert, D. G. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3900-15.2016 · Cited by 247 · cited 1×
“In PD, miR155 has been linked to microglial inflammatory response induced by α-synuclein [23].”
BackgroundMicroRNA‐155 negatively affects blood–brain barrier function during neuroinflammation
Lopez‐Ramirez, M. A., Wu, D., Pryce, G., Simpson, J. E., Reijerkerk, A., King‐Robson, J., Kay, O., de Vries, H. E., Hirst, M. C., Sharrack, B., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-248880 · Cited by 233
Neutrophil extracellular trap induced by HMGB1 exacerbates damages in the ischemic brain
Kim, S.-W., Lee, H., Lee, H.-K., Kim, I.-D., & Lee, J.-K. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0747-x · Cited by 233
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain
Pegtel, D. M., Peferoen, L., & Amor, S. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0516 · Cited by 232 · cited 1×
“EVs are a recognized contributor to neurodegenerative diseases, and both neurotoxic and neuroprotective roles via distribution of EV-mediated cargo, including microRNAs and misfolded proteins, have been implicated [16,17].”
BackgroundThe protein arginine deiminases: Structure, function, inhibition, and disease
Bicker, K. L., & Thompson, P. R. (2013) · Biopolymers · doi:10.1002/bip.22127 · Cited by 230
Slota, J. A., & Booth, S. A. (2019) · Non-Coding RNA · doi:10.3390/ncrna5020035 · Cited by 229
Role of Exosomes in Central Nervous System Diseases
Liu, W., Bai, X., Zhang, A., Huang, J., Xu, S., & Zhang, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00240 · Cited by 221
Neuropsychiatric lupus: a mosaic of clinical presentations
Kivity, S., Agmon-Levin, N., Zandman-Goddard, G., Chapman, J., & Shoenfeld, Y. (2015) · BMC Medicine · doi:10.1186/s12916-015-0269-8 · Cited by 220
MicroRNA-21 Regulates Astrocytic Response Following Spinal Cord Injury
Bhalala, O. G., Pan, L., Sahni, V., McGuire, T. L., Gruner, K., Tourtellotte, W. G., & Kessler, J. A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.3860-12.2012 · Cited by 220
Cloning, Pharmacological Characterization and Brain Distribution of the Rat Apelin Receptor
De Mota, N., Lenkei, Z., & Llorens-Cortès, C. (2000) · Neuroendocrinology · doi:10.1159/000054609 · Cited by 218
(2017) · Anticancer Research · doi:10.21873/anticanres.12107 · Cited by 210
Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System
Carpanini, S. M., Torvell, M., & Morgan, B. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00362 · Cited by 207
Alvarez-Erviti, L., Seow, Y., Schapira, A. H., Rodriguez-Oroz, M. C., Obeso, J. A., & Cooper, J. M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.73 · Cited by 204
Calcium and Parkinson's disease
Surmeier, D. J., Schumacker, P. T., Guzman, J. D., Ilijic, E., Yang, B., & Zampese, E. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.168 · Cited by 202
Haqqani, A. S., Delaney, C. E., Tremblay, T.-L., Sodja, C., Sandhu, J. K., & Stanimirovic, D. B. (2013) · Fluids and Barriers of the CNS · doi:10.1186/2045-8118-10-4 · Cited by 198
Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases
Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 197
Ferrer, I., Martinez, A., Blanco, R., Dalfó, E., & Carmona, M. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-010-0482-8 · Cited by 192 · cited 1×
“The metabolic landscape of neurodegenerative diseases is therefore receiving increased attention [65] and alterations in metabolic pathways in PD, including in early pre-motor stages in PD, have been discussed [66].”
BackgroundWorm, J., Stenvang, J., Petri, A., Frederiksen, K. S., Obad, S., Elmén, J., Hedtjärn, M., Straarup, E. M., Hansen, J. B., & Kauppinen, S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp577 · Cited by 192
Guedes, J. R., Custódia, C. M., Silva, R. J., de Almeida, L. P., Pedroso de Lima, M. C., & Cardoso, A. L. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu348 · Cited by 170
Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease
Carreras, M. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.02.014 · Cited by 167 · cited 2×
“Alteration in mitochondrial complexes, restricting energy output, are related to sepsis as well as PD [57] and implicated in other neurodegenerative disease such as AD, as well as being associated with diabetes [60].”
BackgroundMitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas
Area-Gomez, E., Guardia-Laguarta, C., Schon, E. A., & Przedborski, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120848 · Cited by 164 · cited 1×
“While oxidative stress has been shown to play significant roles both in the onset and progression of PD [40], it still remains open to debate whether the mitochondrial respiratory deficiencies observed in a range of neurodegenerative disorders are initiators or consequences of prior insult [41].”
BackgroundHarrison, E. B., Hochfelder, C. G., Lamberty, B. G., Meays, B. M., Morsey, B. M., Kelso, M. L., Fox, H. S., & Yelamanchili, S. V. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12092 · Cited by 151
Kosgodage, U., Trindade, R., Thompson, P., Inal, J., & Lange, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051007 · Cited by 151
Self-citationEvidence of Inflammatory System Involvement in Parkinson’s Disease
Chao, Y., Wong, S. C., & Tan, E. K. (2014) · BioMed Research International · doi:10.1155/2014/308654 · Cited by 150
Picca, A., Guerra, F., Calvani, R., Marini, F., Biancolillo, A., Landi, G., Beli, R., Landi, F., Bernabei, R., Bentivoglio, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020504 · Cited by 135 · cited 4×
“For example, PD patients have been shown to have greater amounts of circulating small EVs [22].”
BackgroundInfluentialHan, Z., Chen, F., Ge, X., Tan, J., Lei, P., & Zhang, J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.07.045 · Cited by 128
Wang, Y., Hancock, A. M., Bradner, J. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D. R., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.006 · Cited by 128 · cited 1×
“of disease has been related to C3 and factor H levels in PD and AD patients [48].”
BackgroundTNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells
Prajapati, P., Sripada, L., Singh, K., Bhatelia, K., Singh, R., & Singh, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.11.019 · Cited by 123
Acharya, N. K., Nagele, E. P., Han, M. C., Coretti, N. J., DeMarshall, C. A., Kosciuk, M. C., Boulos, P. A., & Nagele, R. G. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.03.004 · Cited by 122
Kholia, S., Jorfi, S., Thompson, P. R., Causey, C. P., Nicholas, A. P., Inal, J. M., & Lange, S. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.26192 · Cited by 122
Self-citationLinking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration
Jha, S. K., Jha, N. K., Kumar, D., Ambasta, R. K., & Kumar, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.015 · Cited by 122
Protein deiminases: New players in the developmentally regulated loss of neural regenerative ability
Lange, S., Gögel, S., Leung, K., Vernay, B., Nicholas, A. P., Causey, C. P., Thompson, P. R., Greene, N. D. E., & Ferretti, P. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.04.015 · Cited by 117
Self-citationAymerich, M. S., Aso, E., Abellanas, M. A., Tolón, R. M., Ramos, J. A., Ferrer, I., Romero, J., & Fernández‐Ruíz, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.016 · Cited by 117
Zhang, L., Dong, L., Li, Y., Hong, Z., & Wei, W. (2012) · Glia · doi:10.1002/glia.22404 · Cited by 116
Functional characterization of alpha-synuclein protein with antimicrobial activity
Park, S., Moon, J. C., Shin, S. Y., Son, H., Jung, Y. J., Kim, N.-H., Kim, Y., Jang, M.-K., & Lee, J. R. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.08.052 · Cited by 114 · cited 1×
“aureus, alongside other bacteria and fungi [69].”
Iturrioz, X., Alvear‐Perez, R., De Mota, N., Franchet, C., Guillier, F., Leroux, V., Dabire, H., Le Jouan, M., Chabane, H., Gerbier, R., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-140715 · Cited by 112
Nicholas, A. P., & Whitaker, J. N. (2002) · Glia · doi:10.1002/glia.10039 · Cited by 109
Harischandra, D. S., Ghaisas, S., Rokad, D., Zamanian, M., Jin, H., Anantharam, V., Kimber, M., Kanthasamy, A., & Kanthasamy, A. G. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2017.04.007 · Cited by 105
Peptidyl Arginine Deiminase from Porphyromonas gingivalis Abolishes Anaphylatoxin C5a Activity
Bielecka, E., Scavenius, C., Kantyka, T., Jusko, M., Mizgalska, D., Szmigielski, B., Potempa, B., Enghild, J. J., Prossnitz, E. R., Blom, A. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.c114.617142 · Cited by 102
Lange, S., Rocha‐Ferreira, E., Thei, L., Mawjee, P., Bennett, K., Thompson, P. R., Subramanian, V., Nicholas, A. P., Peebles, D., Hristova, M., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12744 · Cited by 101
Self-citationOxidative Stress and Gut-Derived Lipopolysaccharides in Neurodegenerative Disease: Role of NOX2
Loffredo, L., Ettorre, E., Zicari, A. M., Inghilleri, M., Nocella, C., Perri, L., Spalice, A., Fossati, C., De Lucia, M. C., Pigozzi, F., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8630275 · Cited by 100 · cited 4×
“Roles for the gut microbiota in neuroinflammation has also been hypothesised and assessed for other neurodegenerative diseases, including AD and amyotrophic lateral sclerosis (ALS) [73].”
BackgroundInfluentialDepboylu, C., Schäfer, M. K.-H., Arias-Carrión, O., Oertel, W. H., Weihe, E., & Höglinger, G. U. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820805b9 · Cited by 89
Kosgodage, U. S., Matewele, P., Mastroianni, G., Kraev, I., Brotherton, D., Awamaria, B., Nicholas, A. P., Lange, S., & Inal, J. M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00227 · Cited by 85 · cited 1×
“Deimination has previously been associated with bacterial immune evasion [71], as well as with bacterial membrane vesicle release and antibiotic resistance, highlighting roles for PAD-mediated mechanisms in host–pathogen interactions [6].”
BackgroundSelf-citationLuo, S., Kang, S. S., Wang, Z.-H., Liu, X., Day, J. X., Wu, Z., Peng, J., Xiang, D., Springer, W., & Ye, K. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0625-19.2019 · Cited by 84
Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic α-MSH release
Goazigo, A. R.-L., Bodineau, L., Mota, N. D., Jeandel, L., Chartrel, N., Knauf, C., Raad, C., Valet, P., & Llorens‐Cortés, C. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00090.2011 · Cited by 83
Distribution of interneurons in the CA2 region of the rat hippocampus
Botcher, N. A., Falck, J. E., Thomson, A. M., & Mercer, A. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00104 · Cited by 82
Self-citationNovel compounds for the modulation of mTOR and autophagy to treat neurodegenerative diseases
Heras-Sandoval, D., Pérez-Rojas, J. M., & Pedraza-Chaverri, J. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109442 · Cited by 80
miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease
Mushtaq, G., H. Greig, N., Anwar, F., A. Zamzami, M., Choudhry, H., M. Shaik, M., A. Tamargo, I., & A. Kamal, M. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151030112140 · Cited by 78
Ishigami, A., Masutomi, H., Handa, S., Nakamura, M., Nakaya, S., Uchida, Y., Saito, Y., Murayama, S., Jang, B., Jeon, Y., et al. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23620 · Cited by 77
miRNA in multiple sclerosis: search for novel biomarkers
Gandhi, R. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515578771 · Cited by 77
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
Talarico, G., Trebbastoni, A., Bruno, G., & de Lena, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180702144644 · Cited by 77
Arendt, T., & Bullmann, T. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00117.2013 · Cited by 75 · cited 1×
“Interestingly, thermogenesis is also linked to CNS activity in hibernating animals [61,62].”
BackgroundAminyavari, S., Zahmatkesh, M., Farahmandfar, M., Khodagholi, F., Dargahi, L., & Zarrindast, M.-R. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.10.005 · Cited by 74
Kosgodage, U. S., Onganer, P. U., MacLatchy, A., Kraev, I., Chatterton, N. P., Nicholas, A. P., Inal, J. M., & Lange, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010103 · Cited by 73 · cited 1×
“EV isolation was carried out according to previously established protocols [5,7,54] as well as the recommendations of the International Society of Extracellular Vesicle Research (ISEV) [152].”
MethodSelf-citationTherapeutic potential of interfering with apelin signalling
Sorli, S., Berghe, L. V. D., Masri, B., Knibiehler, B., & Audigier, Y. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.011 · Cited by 72 · cited 1×
“Apelin signalling is involved in a broad range of physiological functions and furthermore associated with pathologies that result from decreased vascularisation—for example ischaemia, or neovascularisations events such as tumours and retinopathes [79].”
BackgroundApelin, a promising target for Alzheimer disease prevention and treatment
Masoumi, J., Abbasloui, M., Parvan, R., Mohammadnejad, D., Pavon-Djavid, G., Barzegari, A., & Abdolalizadeh, J. (2018) · Neuropeptides · doi:10.1016/j.npep.2018.05.008 · Cited by 72
Role of neuroinflammation and latent transcription factors in pathogenesis of Parkinson’s disease
Pal, R., Tiwari, P. C., Nath, R., & Pant, K. K. (2016) · Neurological Research · doi:10.1080/01616412.2016.1249997 · Cited by 71
Identification of molecular correlations of RBM8A with autophagy in Alzheimer's disease
Zou, D., Li, R., Huang, X., Chen, G., Liu, Y., Meng, Y., Wang, Y., Wu, Y., & Mao, Y. (2019) · Aging · doi:10.18632/aging.102571 · Cited by 70
Jang, B., Jin, J., Jeon, Y., Cho, H. J., Ishigami, A., Choi, K., Carp, R. I., Maruyama, N., Kim, Y., & Choi, E. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0625-x · Cited by 69
Lange, S., Gallagher, M., Kholia, S., Kosgodage, U. S., Hristova, M., Hardy, J., & Inal, J. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061196 · Cited by 69 · cited 1×
“Both protein deimination and EVs are gaining increasing attention in relation to neurodegenerative diseases [8,9], including in PD, while their roles in pre-motor PD have yet to be investigated.”
BackgroundSelf-citationJiang, R., Rong, C., Ke, R., Meng, S., Yan, X., Ke, H., & Wu, S. (2019) · Medicine · doi:10.1097/md.0000000000017478 · Cited by 68
Klotzsch, E., Тихоновна, С. А., Löfler, L., Moldzio, R., Parkinson, E., Schütz, G. J., & Pohl, E. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415261112 · Cited by 66 · cited 1×
“Thermogenesis is related to mitochondrial function [57,58] and also linked to synaptic transmission and neurodegeneration [59].”
BackgroundZhu, J., Gao, W., Shan, X., Wang, C., Wang, H., Shao, Z., Dou, S., Jiang, Y., Wang, C., & Cheng, B. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146493 · Cited by 65
MicroRNAs as diagnostic markers and therapeutic targets for traumatic brain injury
Peplow, P., & Martinez, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.219025 · Cited by 63 · cited 1×
“Moreover, miR21 has been identified as a biomarker in plasma/serum for AD, prion disease, as well as traumatic brain injury [24,124,133,134], where it has also been found to be increased in EVs [135].”
BackgroundJang, B., Ishigami, A., Maruyama, N., Carp, R. I., Kim, Y., & Choi, E. (2013) · Prion · doi:10.4161/pri.22380 · Cited by 62
Implications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
The multiple roles of exosomes in Parkinson's disease: an overview
Porro, C., Panaro, M. A., Lofrumento, D. D., Hasalla, E., & Trotta, T. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1650371 · Cited by 62
Neuronal UCP1 expression suggests a mechanism for local thermogenesis during hibernation
Laursen, W. J., Mastrotto, M., Pesta, D. H., Funk, O. H., Goodman, J. B., Merriman, D. K., Ingolia, N. T., Shulman, G. I., Bagriantsev, S. N., & Gracheva, E. O. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421419112 · Cited by 60 · cited 1×
“Interestingly, thermogenesis is also linked to CNS activity in hibernating animals [61,62].”
BackgroundOnganer, P. U., MacLatchy, A., Rayan, M., Kraev, I., Thompson, P. R., Inal, J. M., & Lange, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041495 · Cited by 57
Self-citationIntegrated Analysis and Identification of Novel Biomarkers in Parkinson’s Disease
Chi, J., Xie, Q., Jia, J., Liu, X., Sun, J., Deng, Y., & Yi, L. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00178 · Cited by 54
Endocannabinoid Signaling in Midbrain Dopamine Neurons: More than Physiology?
Melis, M., & Pistis, M. (2007) · Current Neuropharmacology · doi:10.2174/157015907782793612 · Cited by 53
Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra
Nicholas, A. P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.028 · Cited by 53 · cited 4×
“Such elevated F95 positive detection observed here correlates somewhat with a previous study on human PD post-mortem brain tissue, although that study reported elevation of deiminated proteins in the substantia nigra [10].”
BackgroundResultInfluentialZhu, J., Dou, S., Jiang, Y., Chen, J., Wang, C., & Cheng, B. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.027 · Cited by 52 · cited 1×
“Apelin signalling has been linked to autophagy in PD, both in cellular in vitro and in vivo mouse models [90,92].”
BackgroundPicca, A., Calvani, R., Landi, G., Marini, F., Biancolillo, A., Gervasoni, J., Persichilli, S., Primiano, A., Urbani, A., Bossola, M., et al. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110766 · Cited by 51
Mitochondrial Perturbation in Alzheimer's Disease and Diabetes
Akhter, F., Chen, D., Yan, S. F., & Yan, S. S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.019 · Cited by 50 · cited 1×
“Alteration in mitochondrial complexes, restricting energy output, are related to sepsis as well as PD [57] and implicated in other neurodegenerative disease such as AD, as well as being associated with diabetes [60].”
BackgroundStrategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium
Enders, M., Heider, T., Ludwig, A., & Küerten, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051663 · Cited by 50
Voloboueva, L. A., Sun, X., Xu, L., Ouyang, Y., & Giffard, R. G. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1777-16.2017 · Cited by 46
Renani, P. G., Taheri, F., Rostami, D., Farahani, N., Abdolkarimi, H., Abdollahi, E., Taghizadeh, E., & Hayat, S. M. G. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28622 · Cited by 45 · cited 2×
“Epigenetic mechanisms of PD have indeed received increasing attention, including histone modifications, DNA methylation, as well as microRNA involvement [26,27].”
BackgroundRaman profiling of circulating extracellular vesicles for the stratification of Parkinson’s patients
Gualerzi, A., Picciolini, S., Carlomagno, C., Terenzi, F., Ramat, S., Sorbi, S., & Bedoni, M. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.102097 · Cited by 45 · cited 4×
“Mounting evidence has linked EVs to neurodegenerative diseases, indicating critical roles for EV-mediated transport of pathogenic protein and genetic cargo, including in PD [21,22].”
BackgroundInfluentialMagnadóttir, B., Kraev, I., Guðmundsdóttir, S., Dodds, A. W., & Lange, S. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103397 · Cited by 44
Self-citationJiang, X., Jin, T., Zhang, H., Miao, J., Zhao, X., Su, Y., & Zhang, Y. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/4578462 · Cited by 43 · cited 1×
“Mitochondria are the key regulators of cellular metabolism and their dysfunction is a hallmark of PD pathogenesis [63].”
BackgroundZhu, J., Dou, S., Jiang, Y., Bai, B., Chen, J., Wang, C., & Cheng, B. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.047 · Cited by 42
Clinical features and predictive factors in neuropsychiatric lupus.
Chiewthanakul, P., Sawanyawisuth, K., Foocharoen, C., & Tiamkao, S. (2012) · PubMed · Cited by 41
The endocannabinoid system in neuropathological states
Martínez-Orgado, J. A., Fernández‐Ruíz, J., & Romero, J. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782828 · Cited by 40
Reversible parkinsonism in systemic lupus erythematosus
Tan, E., Chan, L. L., & Auchus, A. P. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00604-9 · Cited by 40
Liu, B., Wei, H., Lan, M., Jia, N., Liu, J., & Zhang, M. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8421 · Cited by 40
Parkinsonian Syndrome Complicating Systemic Lupus Erythematosus
Shahar, E. M., Goshen, E., Tauber, Z., & Lahat, E. (1998) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00229-4 · Cited by 39
Mashima, K., Takahashi, S., Minami, K., Izawa, Y., Abe, T., Tsukada, N., Hishiki, T., Suematsu, M., Kajimura, M., & Suzuki, N. (2018) · ASN NEURO · doi:10.1177/1759091418775562 · Cited by 39 · cited 1×
“While oxidative stress has been shown to play significant roles both in the onset and progression of PD [40], it still remains open to debate whether the mitochondrial respiratory deficiencies observed in a range of neurodegenerative disorders are initiators or consequences of prior insult [41].”
BackgroundDual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex
Nicholas, A. P. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.028 · Cited by 38
Mechanisms Involved in Dual Vasopressin/Apelin Neuron Dysfunction during Aging
Sauvant, J., Delpech, J.-C., Palin, K., Mota, N. D., Dudit, J., Aubert, A., Orcel, H., Roux, P., Layé, S., Moos, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087421 · Cited by 36
Magnadóttir, B., Bragason, B. Þ., Bricknell, I. R., Bowden, T. J., Nicholas, A. P., Hristova, M., Guðmundsdóttir, S., Dodds, A. W., & Lange, S. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.10.016 · Cited by 36
Self-citationDeus, C. M., Pereira, S. P., Cunha-Oliveira, T., Pereira, F. B., Raimundo, N., & Oliveira, P. J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165615 · Cited by 36
Magnadóttir, B., Hayes, P. M., Gísladóttir, B., Bragason, B. Þ., Hristova, M., Nicholas, A. P., Guðmundsdóttir, S., & Lange, S. (2018) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2018.05.014 · Cited by 35
Self-citationmiRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
Liu, X., Chen, J., Guan, T., Yao, H., Zhang, W., Guan, Z., & Wang, Y. (2019) · BMC Systems Biology · doi:10.1186/s12918-019-0680-4 · Cited by 35 · cited 2×
“Epigenetic mechanisms of PD have indeed received increasing attention, including histone modifications, DNA methylation, as well as microRNA involvement [26,27].”
BackgroundEstrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 35
Inverse Association of Parkinson Disease With Systemic Lupus Erythematosus
Liu, F., Huang, W., Lin, T., Shen, C., Chou, Y., Lin, C., Lin, K., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000002097 · Cited by 34
Pamenter, M. E., Onganer, P. U., Huynh, K. W., Kraev, I., & Lange, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215378 · Cited by 34 · cited 2×
“F95 enrichment of deiminated proteins was carried out according to previously described protocols [7,53,54].”
MethodSelf-citationIlie, O., Ciobica, A. S., McKenna, J., Doroftei, B., & Mavroudis, I. A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4518023 · Cited by 33 · cited 1×
“This may be of some interest as the brain–gut axis relationship between the gut microflora and PD has been a topic of investigation due to gastrointestinal symptoms being one of the earliest features of PD [72].”
BackgroundThe role and therapeutic potential of connexins, pannexins and their channels in Parkinson's disease
Ahmadian, E., Eftekhari, A., Samiei, M., Dizaj, S. M., & Vinken, M. (2019) · Cellular Signalling · doi:10.1016/j.cellsig.2019.03.010 · Cited by 32
Aminyavari, S., Zahmatkesh, M., Khodagholi, F., & Sanati, M. (2019) · Peptides · doi:10.1016/j.peptides.2019.170102 · Cited by 30
Deiminated proteins and extracellular vesicles - Novel serum biomarkers in whales and orca
Magnadóttir, B., Onganer, P. U., Kraev, I., Svansson, V., Hayes, P. M., & Lange, S. (2020) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2020.100676 · Cited by 30
Self-citationLange, S., Kraev, I., Magnadóttir, B., & Dodds, A. W. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.103437 · Cited by 29
Self-citationPallidal gap junctions‐triggers of synchrony in Parkinson's disease?
Schwab, B. C., Heida, T., Zhao, Y., van Gils, S. A., & Wezel, R. J. A. V. (2014) · Movement Disorders · doi:10.1002/mds.25987 · Cited by 28
Protein Deimination in Human Health and Disease
Kizawa, K., Unno, M., Heizmann, C. W., & Takahara, H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8317-5 · Cited by 28
Jang, B., Jeon, Y., Shin, H., Lee, Y.-J., Kim, H., Kondo, Y., Ishigami, A., Kim, Y., & Choi, E. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0560-0 · Cited by 28
Neuropsychiatric systemic lupus erythematosus in elderly people: a case series.
Dennis, M., Byrne, E. J., Hopkinson, N., & Bendall, P. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.12.1157 · Cited by 27
Peptidylarginine Deiminases as Drug Targets in Neonatal Hypoxic–Ischemic Encephalopathy
Lange, S. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00022 · Cited by 27
Self-citationMicroRNAs to differentiate Parkinsonian disorders: Advances in biomarkers and therapeutics
Ramaswamy, P., Christopher, R., Pal, P. K., & Yadav, R. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.08.032 · Cited by 27
Protein Deimination and Extracellular Vesicle Profiles in Antarctic Seabirds
Phillips, R. A., Kraev, I., & Lange, S. (2020) · Biology · doi:10.3390/biology9010015 · Cited by 27
Self-citationProtein Deimination in Human Health and Disease
Gawron, K., Montgomery, A. B., Łazarz‐Bartyzel, K., Bereta, G. P., Chomyszyn‐Gajewska, M., Venables, P. J., Potempa, J., Anthony, N., Paul, T., & Sanjoy, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-58244-3 · Cited by 27
Parkinson-Like Symptoms as a Manifestation of Systemic Lupus Erythematosus
Miyoshi, Y., Atsumi, T., Kitagawa, H., Ogura, N., Amasaki, Y., Tsutsumi, A., Ohnishi, K., Fujisaku, A., Sagawa, A., & Koike, T. (1993) · Lupus · doi:10.1177/096120339300200314 · Cited by 26
An Effective Method to Identify Shared Pathways and Common Factors among Neurodegenerative Diseases
Li, P., Nie, Y., & Yu, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143045 · Cited by 26 · cited 1×
“This is in agreement with previous studies assessing KEGG pathways in AD, PD, and HD, with the aim to identify shared pathways for distinct but related diseases that may share common underlying pathogenic mechanisms [36].”
ResultMicroarray Analysis of the Molecular Mechanism Involved in Parkinson’s Disease
Tan, C. Y., Liu, X., & Chen, J. (2018) · Parkinson s Disease · doi:10.1155/2018/1590465 · Cited by 26 · cited 1×
“KEGG pathways for metabolic pathways have been linked to PD development based on microarray analysis of blood samples from PD patients and matched controls [67].”
BackgroundPhookan, S., Sutton, A. C., Walling, I. T., Smith, A. B., O'Connor, K. A., Campbell, J. C., Calos, M. E., Yu, W., Pilitsis, J. G., Brotchie, J. M., et al. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.01.004 · Cited by 25
Kanata, Ε., Thüne, K., Xanthopoulos, K., Ferrer, I., Dafou, D., Zerr, I., Sklaviadis, T., & Llorens, F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00220 · Cited by 25
Peripheral Humoral Immune Response Is Associated With the Non-motor Symptoms of Parkinson’s Disease
Sun, C., Yu, W., Zhao, Z., Song, C., Liu, Y., Jia, G., Wang, X., & Liu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01057 · Cited by 25 · cited 2×
“Interestingly, levels of the key complement components of the alternative and classical pathways, C3 and C4, were previously reported to be lower in non-motor PD compared with healthy controls [47], while severity”
BackgroundNeurotoxic and Neuroprotective Role of Exosomes in Parkinson’s Disease
Longoni, B., Fasciani, I., Kolachalam, S., Pietrantoni, I., Marampon, F., Petragnano, F., Aloisi, G., Coppolino, M. F., Rossi, M., Scarselli, M., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191113103537 · Cited by 25
Lim, K., Kim, H., Bae, O., Noh, J.-Y., Kim, K., Kim, S.-H., Chung, S.-M., Shin, S., Kim, H., & Chung, J. (2009) · Platelets · doi:10.1080/09537100902721746 · Cited by 24
Berghuis, P., Dobszay, M. B., Martín‐Ibáñez, R., Ernfors, P., & Harkany, T. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.012 · Cited by 24
Structural Changes Observed in the Piriform Cortex in a Rat Model of Pre-motor Parkinson’s Disease
Sancandi, M., Schul, E. V., Economides, G., Constanti, A., & Mercer, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00479 · Cited by 24 · cited 7×
“As neuroinflammation is thought to be a facilitator of PD pathogenesis, and was observed in the pre-motor PD model used in this study [32,125], we assessed changes in relative expression levels of three inflammatory and hypoxia associated microRNAs: miR21, miR155, and miR210.”
BackgroundMethodInfluentialSelf-citationCitrullination Inactivates Nicotinamide-N-methyltransferase
Nemmara, V. V., Tilvawala, R. R., Salinger, A. J., Miller, L., Nguyen, S. H., Weerapana, E., & Thompson, P. R. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00578 · Cited by 22
Zhu, J., Dou, S., Wang, C., Jiang, Y., Wang, C., & Cheng, B. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146334 · Cited by 21
Parkinsonism in Inherited Metabolic Disorders: Key Considerations and Major Features
Limphaibool, N., Iwanowski, P. S., Holstad, M. J. V., & Perkowska, K. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00857 · Cited by 20 · cited 1×
“Furthermore, PD has been linked to a range of inherited metabolic disorders [64].”
BackgroundBrown adipose tissue activation in a rat model of Parkinson’s disease
Wang, W., Meng, X., Yang, C., Fang, D., Wang, X., An, J., Zhang, J., Wang, L., Lu, T., Ruan, H., et al. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00049.2017 · Cited by 19 · cited 1×
“Loss of body weight and fat mass is one of the non-motor symptoms of Parkinson’s disease and has, amongst others, been related to brown fat tissue meditated thermogenesis [56].”
BackgroundBioinformatic analysis of microRNA expression in Parkinson’s disease
Hao, B., Chen, X., Dai, D., ZOU, C., Wu, X. L., & Chen, J. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2837 · Cited by 18
Davydova, T. V., Fomina, V. G., Voskresenskaya, N. I., & Doronina, O. A. (2003) · Bulletin of Experimental Biology and Medicine · doi:10.1023/b:bebm.0000010950.53560.e2 · Cited by 18 · cited 1×
“Interestingly, phagocytic activity and bactericidal activity of neutrophils have been shown to be affected in early AD [70].”
BackgroundOngoing Studies of Deimination in Neurodegenerative Diseases Using the F95 Antibody
Nicholas, A. P., Lu, L., Heaven, M. R., Kadish, I., van Groen, T., Accavitti-Loper, M. A., Wewering, S., Kofskey, D., Gambetti, P. L., & Brenner, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8317-5_14 · Cited by 16 · cited 2×
“Protein deimination has previously been linked to AD [11,29–31], PD [10,12], and prion disease, including Creutzfeldt–Jakob disease (CJD) [33–35].”
BackgroundLi, N., Wu, Y., Zhu, L., Huang, Y., Liu, Z., Shi, M., Soltys, D., Zhang, J., & Chang, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.084 · Cited by 16
Conjunctival Flora in Patients with Parkinson's Disease
Küsbeci, T., Küsbeci, Ö. Y., Aktepe, O. C., Yavaş, G. F., & Ermiş, S. S. (2009) · Current Eye Research · doi:10.1080/02713680902725970 · Cited by 14 · cited 1×
“aureus has been found to be significantly increased in the conjunctival flora in PD patients [68].”
BackgroundWang, Y., Zhang, Q., Wang, H. S., Wang, T., & Liu, J. (2014) · Synapse · doi:10.1002/syn.21740 · Cited by 14
Zhou, Y., Su, Y., Xu, W., Wang, W., & Yao, S. (2019) · Current Neurovascular Research · doi:10.2174/1567202616666190618170103 · Cited by 12 · cited 1×
“Furthermore, the involvement of inflammatory factors and modified inflammatory responses and their involvement with the brain–gut axis of PD also needs consideration [55]; particularly if such factors can be identified at early stages of disease.”
BackgroundLange, S., Wray, S., Devine, M. J., Matarín, M., & Hardy, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-58244-3_13 · Cited by 7 · cited 4×
“Both protein deimination and EVs are gaining increasing attention in relation to neurodegenerative diseases [8,9], including in PD, while their roles in pre-motor PD have yet to be investigated.”
BackgroundResultInfluentialSelf-citationKarki, R., Kodamullil, A. T., Hoyt, C. T., & Hofmann‐Apitius, M. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3101-1 · Cited by 6 · cited 1×
“Mitochondrial dysfunction has been found to be severe in cortex and in advanced stages of PD patients, based on algorithm analysis [42].”
BackgroundDeimination in Alzheimer’s Disease
Ishigami, A., Choi, E., Kim, Y., & Maruyama, N. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8317-5_13 · Cited by 5
Özcan, E., & Çakır, T. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-94593-4_7 · Cited by 4
Cited by
Extracellular Vesicles: Current Analytical Techniques for Detection and Quantification
Serrano-Pertierra, E., Oliveira-Rodríguez, M., Matos, M., Gutiérrez, G., Moyano, A., Salvador, M., Rivas, M., & Blanco-López, M. (2020) · Biomolecules · doi:10.3390/biom10060824 · Cited by 94
“Recently, EV numbers were too found higher in a rat model of Parkinson disease [42].”
BackgroundGorgzadeh, A., Nazari, A., Ismaeel, A. A. E., Safarzadeh, D., Hassan, J. A. K., Mohammadzadehsaliani, S., Kheradjoo, H., Yasamineh, P., & Yasamineh, S. (2024) · Virology Journal · doi:10.1186/s12985-024-02301-5 · Cited by 73
“Using the NTA technique, researchers observed that individuals with breast cancer or PCa had significantly greater levels of EV compared to healthy controls [89, 94, 95].”
MethodMetabolic Crosstalk between Liver and Brain: From Diseases to Mechanisms
Yang, X., Qiu, K., Jiang, Y., Huang, Y., Zhang, Y., & Liao, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147621 · Cited by 84
“It is worth continuing to study the effects of liver factors on the central nervous system and the sites of action, and trying to find specific drugs that regulate the central metabolism.”
BackgroundJiang, R., Rong, C., Ke, R., Meng, S., Yan, X., Ke, H., & Wu, S. (2019) · Medicine · doi:10.1097/md.0000000000017478 · Cited by 68
Yasamineh, S., Nikben, N., Ahmed, M. H., Kareem, R. A., Al-Aridhy, A. K., & Hooshiar, M. H. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03379-1 · Cited by 44
“EV levels were recently discovered to be elevated in a rodent model of Parkinson’s disease [91, 94, 95].”
Background
Metadata
- Authors
- Sancandi, M., Uysal-Onganer, P., Kraev, I., Mercer, A., & Lange, S.
- Affiliations
- UCL School of Pharmacy (GB)
- Cancer Research Group, School of Life Sciences, University of Westminster, London W1W 6XH, UK
- The Open University (GB)
- University of Westminster (GB)
- Corresponding author
- Lange, Sigrun
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-04-15
- Volume
- 21
- Issue
- 8
- Pages
- 2743
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7215947
- OpenAlex
- W3017346163
- Cited by
- 41
- References
- 159
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 8 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 5
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Open Research Online - ORO (The Open University) (acceptedVersion)
- WestminsterResearch (University of Westminster) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University of Westminster
- School of Pharmacy, University College London
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Parkinson's disease, peptidylarginine deiminase, protein deimination, extracellular vesicles, plasma biomarkers, cerebral vasculature, microRNA, MIR21, miR-155, oxidative phosphorylation, neuroinflammation, hypoxia
- MeSH terms
- Extracellular Vesicles, Citrullination, Protein-Arginine Deiminases, Animals, Brain, Chromatography, Liquid, Disease Models, Animal, Immunohistochemistry, Male, Parkinson Disease, Protein Processing, Post-Translational, Biomarkers, Rats, Sprague-Dawley, MicroRNAs, Proteomics, Microscopy, Electron, Transmission, Rats, Tandem Mass Spectrometry, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.